Clinical Trials Logo

Meralgia Paresthetica clinical trials

View clinical trials related to Meralgia Paresthetica.

Filter by:
  • None
  • Page 1

NCT ID: NCT06251882 Completed - Clinical trials for Meralgia Paresthetica

Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Meralgia paresthetica (MP) is one of the most common peripheral entrapment neuropathies of the lower limbs. It is characterized by paresthesia, pain, tingling, numbness, hypersensitivity, or other abnormal skin sensations on the anterolateral aspect of the thigh. The condition results from compression of the lateral femoral cutaneous nerve (LFCN) along its course, often occurring as the nerve exits the pelvis.The injection of 5% dextrose (D5W) under ultrasound guidance is a novel treatment method for peripheral nerve entrapment. However, there is limited evidence about the efficacy of this method for patients with MP. The investigators found D5W was more safe and effective than corticosteroids for patients with MP. Thus, this study aimed to evaluate the 6-month efficacy of ultrasound-guided injection of D5W for MP patients.

NCT ID: NCT06187883 Completed - Clinical trials for Meralgia Paresthetica

Pulsed Radiofrequency of Lateral Femoral Cutaneous Nerve

Start date: November 21, 2023
Phase:
Study type: Observational

In the current retrospective cohort study, conducted by both pain specialists and neurophysiologists, the primary outcome was to search for the effect of obesity on the efficacy of PRF of LFCN in refractory MP for 6 months. Secondary outcomes were to identify the clinical and diagnostic features of the MP.

NCT ID: NCT05893732 Recruiting - Clinical trials for Meralgia Paresthetica

HILT for Meralgia Paresthetica: A Randomized Controlled Trial

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

This randomized controlled trial aims to investigate the efficacy of High-Intensity Laser Therapy (HILT) in the management of Meralgia Paresthetica (MP), a peripheral neuropathy causing pain, numbness, and tingling in the thigh region. Participants with MP will be randomly allocated to either the HILT or sham HILT (control) group. The study will evaluate the effects of HILT on pain intensity, functional outcomes, and quality of life. Findings from this trial will provide insights into the potential benefits of HILT as a non-invasive and safe treatment option for patients with MP.

NCT ID: NCT04747119 Completed - Clinical trials for Meralgia Paresthetica

Effect of MET on Meralgia Paraesthesia Postpartum "Muscle Energy Technique"

MET
Start date: October 1, 2020
Phase: N/A
Study type: Interventional

To investigate the effect of muscle energy technique on Femoral meralgia paraesthesia in a postpartum female. BACKGROUND: meralgia paraesthesia is one of the serious disorders in the postpartum female which results in pain and less physical activities. ………HYPOTHESES: This study hypothesized that: muscle energy technique will have a significant effect on Femoral meralgia paraesthesia in postpartum female

NCT ID: NCT04499911 Completed - Clinical trials for Meralgia Paresthetica

Efficacy of Neural Prolotherapy in Treatment of Meralgia Paresthetica

Start date: April 15, 2018
Phase: N/A
Study type: Interventional

Meralgia paresthetica is an entrapment neuropathy of the lateral femoral cutaneous nerve. Its main manifestation is neuropathic pain on the lateral aspect of the thigh. Neural prolotherapy has shown improvement and relieve of neuropathic pain. The aim of the current study was to assess the efficacy of neural prolotherapy (subcutaneous perineural injection of dextrose 5% solution) on reliving pain and improvement of function and quality of life in patients with meralgia paresthetica.

NCT ID: NCT04046406 Withdrawn - Low Back Pain Clinical Trials

Pelvic Pain Treated With MR-guided Cryoanalgesia

Start date: November 13, 2019
Phase: N/A
Study type: Interventional

Pelvic pain syndromes have a high prevalence of up to 8% in the general population and up to 50% following pelvic trauma and pelvic surgery. While medical management is the initial therapeutic step, it is often ineffective with surgical decompression and resection of the putative nerves being the ultima ratio. Cryoablation can induce long-lasting nerve conduction blocks with resultant pain relief for several months. The objective of this study is to evaluate the effectiveness of magnetic resonance (MR) neurography-guided cryoanalgesia for the treatment of pelvic and associated pain syndromes.

NCT ID: NCT04004052 Completed - Clinical trials for Meralgia Paresthetica

Conservative Treatment and Ultrasound Guided Injection for Treatment Meralgia Paresthetica

Start date: January 1, 2014
Phase: N/A
Study type: Interventional

Meralgia paresthetica (MP) is an entrapment mononeuropathy of the lateral femoral cutaneous nerve (LFCN), where conservative treatment options are not always sufficient. The aim of this study was to evaluate the efficacy of ultrasound (US) guided lateral femoral cutaneous nerve injection in the management of meralgia paresthetica by comparing with transcutaneous electrical nerve stimulation (TENS) therapy and sham transcutaneous electrical nerve stimulation therapy.

NCT ID: NCT02577510 Completed - Clinical trials for Meralgia Paresthetica

Comparing Ways to Freeze the Nerve That Provides Thigh Sensation

Start date: November 2015
Phase: Phase 3
Study type: Interventional

Background The sensation on the outside of portion of our thighs is provided by a nerve called the lateral femoral cutaneous nerve (LFCN). The investigators can inject freezing around the nerve to reduce the feeling around the thigh (i.e. anesthesia). Anesthesia, or freezing, of the lateral femoral cutaneous nerve can reduce pain for patients having A) hip and knee surgery [1,2], B) removal of a skin graft [3], and C) wound care. In addition, damage to the LFCN (i.e. Meralgia Paresthetica) has been associated with body armour and gun belt use in military and police personnel [4]. Although generally a benign condition, compression or injury to this nerve can be painful and require treatment. In addition, the actual variability in sensory distribution for this nerve has not been elucidated in a topographical fashion and will be measured in this study. Finding the most efficient and effective method for anesthesia of the LFCN can improve and positively impact the quality of pain control for patients. Ultrasound has improved the accuracy and efficiency of various other regional anesthesia techniques, and could also impact the safety. Therefore the investigators hypothesize that ultrasound guided lateral femoral cutaneous nerve block using the subinguinal technique will be statistically more efficacious and efficient when compare to neurostimulation based blockade.